Angiographic complexity of coronary artery disease according to SYNTAX score and clinical outcomes after revascularisation with newer-generation drug-eluting stents: a substudy of the BIOSCIENCE trial.

Détails

ID Serval
serval:BIB_70BACC999793
Type
Article: article d'un périodique ou d'un magazine.
Collection
Publications
Titre
Angiographic complexity of coronary artery disease according to SYNTAX score and clinical outcomes after revascularisation with newer-generation drug-eluting stents: a substudy of the BIOSCIENCE trial.
Périodique
EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology
Auteur(s)
Franzone A., Taniwaki M., Rigamonti F., Heg D., Piccolo R., Roffi M., Tüller D., Muller O., Vuilliomenet A., Cook S., Weilenmann D., Kaiser C., Jamshidi P., Jüni P., Windecker S., Pilgrim T.
ISSN
1969-6213 (Electronic)
ISSN-L
1774-024X
Statut éditorial
Publié
Date de publication
05/08/2016
Peer-reviewed
Oui
Volume
12
Numéro
5
Pages
e595-604
Langue
anglais
Notes
Publication types: Journal Article
Publication Status: epublish
Résumé
We sought to assess the performance of drug-eluting stents combining an ultrathin cobalt-chromium platform with a biodegradable polymer across categories of increasing SYNTAX score (SS).
Patients included in the BIOSCIENCE trial and randomly allocated to treatment with biodegradable polymer sirolimus-eluting stents (BP-SES) or durable polymer everolimus-eluting stents (DP-EES) were categorised according to SS tertiles (low <8, medium 8-15, high >15). The primary endpoint, target lesion failure (TLF), was defined as a composite of cardiac death, target vessel myocardial infarction and clinically indicated target lesion revascularisation. The patient-oriented endpoint (POCE) included death, myocardial infarction, or any repeat revascularisation. The SS was available in 2,041 out of 2,119 patients (96.3%). At two-year follow-up, patients with an SS >15 experienced higher rates of both TLF and POCE as compared to patients with medium and low SS (14.5% vs. 8.1% and vs. 5.9%, p<0.001; 22.7% vs. 14.9% and vs. 12.4%; p<0.001), respectively. Comparable rates of the composite endpoints were documented for both stent types in each category of SS.
Increasing lesion complexity as assessed by SS was associated with higher rates of TLF and POCE in a contemporary PCI population with minimal exclusion criteria. BP-SES and DP-EES showed comparable performance across the entire spectrum of CAD severity.

Pubmed
Web of science
Création de la notice
12/03/2017 16:45
Dernière modification de la notice
20/08/2019 15:29
Données d'usage